Schedule & Agenda

2019 Schedule & Agenda
BIO Asia Webinar Series
10 Results
Tuesday, March 5
10:30 AM - 10:45 AM (JST)

NBHL has expertise in generating of functional mAbs targeting multispanning membrane protein such…
2nd Floor
11:30 AM - 11:45 AM (JST)

TAGCyx provides unique DNA aptamer with proprietary artificial nucleic acid base. Aptamer is an…
2nd Floor
1:45 PM - 2:00 PM (JST)

VORONOI primarily develops small molecule inhibitors of kinases using kinase profiling and…
2nd Floor
Wednesday, March 6
8:30 AM - 8:45 AM (JST)

AIMM is a preclinical stage company in the process of advancing 2 antibodies into the clinic.
2nd Floor
8:45 AM - 9:00 AM (JST)

Kleo Pharmaceuticals is a unique immuno-oncology company developing next-generation bispecific…
2nd Floor
9:00 AM - 9:15 AM (JST)

Developing an allogeneic regenerative medicinal product for severe heart failure, which is made…
2nd Floor
10:30 AM - 10:45 AM (JST)

HanaVax is developing vaccines administered by small painless sprays into the nose. Our…
2nd Floor
10:45 AM - 11:00 AM (JST)

M Bio Thechnology is a world leading company focused on the discovery and development of innovative…
2nd Floor
2:45 PM - 3:00 PM (JST)

Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of…
2nd Floor
3:00 PM - 3:15 PM (JST)

GEXVal Inc. is a Japanese-based spinoff company from Takeda Pharmaceutical Company Limited,…
2nd Floor